Skip to main content
# Title Research Member Research Year
111 Can Pediatric Risk of Mortality Score (PRISM III) Be Used Effectively in Initial Evaluation and Follow-up of Critically Ill Cancer Patients Admitted to Pediatric Oncology Intensive Care Unit (POICU)? A Prospective Study, in a Tertiary Cancer Center in Egy Prof. Heba Abdel-Razik Sayed Hussein 2017
112 Myocardial Changes in Childhood Cancer Patients Treated with Anthracyclines Prof. Amany Mohamed Ali Ahmed 2017
113 P-459 Myocardial Changes in Childhood Cancer Patients Treated with Anthracyclines Prof. Amany Mohamed Ali Ahmed 2017
114 Environmentally-Mediated Epigenetic Effects: Uncovering the Fertile Soil in the Development of Pediatric Cancer Ameer Mohammed Abuelgheet Mohammed 2017
115 Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours. Prof. Amany Mohamed Ali Ahmed 2016
116 The Outcome of Critically Ill Pediatric Cancer Patients Admitted to the Pediatric Intensive Care Unit in a Tertiary University Oncology Center in a Developing Country: A 5-Year Experience. Prof. Amany Mohamed Ali Ahmed 2016
117 Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours. Prof. Amany Mohamed Ali Ahmed 2016
118 CORRELATION BETWEEN SOME BIOLOGIC AND OTHER PROGNOSTIC MARKERS OF CHILDHOOD NEUROBLASTIC TUMORS Dr. Ahmed Mohammed Morsy Hassan 2016
119 The Outcome of Critically Ill Pediatric Cancer Patients Admitted to the Pediatric Intensive Care Unit in a Tertiary University Oncology Center in a Developing Country: A 5-Year Experience. Prof. Heba Abdel-Razik Sayed Hussein 2016
120 Pain Experience Profile in Children with Cancer: Prospective Analysis of 2216 Treatment Days in a Developing Country Dr. Khaled Fathy Riad Osman 2016